Item 2. Unregistered Sales of Equity Securities
Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds.
Use of Proceeds
In February 2021, our Sponsor paid $25,000, or
approximately $0.003 per share, to cover certain of our offering costs in exchange for 7,187,500 Founder Shares. Subsequently on March
5, 2021, we effected a 1.2 to 1 share recapitalization with respect to our Class B ordinary shares, as a result of which our Sponsor
held 8,625,000 Founder Shares. The number of Founder Shares outstanding was determined based on the expectation that the total size of
our Public Offering would be a maximum of 34,500,000 Units if the underwriters’ over-allotment option is exercised in full and
therefore that such Founder Shares would represent 20% of the outstanding shares after the Public Offering. Up to 1,125,000 of these
shares were subject to surrender for no consideration depending on the extent to which the underwriter’s over-allotment was exercised.
On October 29, 2021, as a result of the partial exercise of the over-allotment option, our Sponsor forfeited 381,250 Founder Shares and
the remaining Founder Shares are no longer subject to forfeiture. Such securities were issued in connection with our organization pursuant
to the exemption from registration contained in Section 4(a)(2) of the Securities Act. No underwriting discounts or commissions were
paid with respect to such sales.
On September 24, 2021, we consummated the IPO
of 30,000,000 Units at $10.00 per Unit. Each Unit consists of one Class A ordinary share, and one-half of one Public Warrant, with each
whole warrant entitling the holder to purchase one Class A ordinary share for $11.50 per share, subject to adjustment. The underwriters
had a 45-day option to purchase up to an additional 4,500,000 Units to cover over-allotments, if any. On October 29, 2021, the underwriters
partially exercised the over-allotment option and purchased 2,975,000 Over-Allotment Units, generating additional gross proceeds of $29,750,000,
and forfeited their option to purchase the remaining 1,535,000 Units. The securities in the Public Offering were registered under the
Securities Act on a registration statement on Form S-1 (No. 333-253963). The SEC declared the registration statement effective on September
21, 2021.
Simultaneously with the closing of the IPO, we
consummated the sale of 6,250,000 Private Placement Warrants to our Sponsor at a price of $1.00 per Private Placement Warrant, generating
total gross proceeds of $6,250,000. On October 29, 2021, simultaneously with the closing of the Over-Allotment, our Sponsor purchased
an additional 595,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, generating aggregate gross proceeds
of $595,000. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
No underwriting discounts or commissions were paid with respect to such sales.
31
We paid a total of $16,908,188 in underwriting
discounts and commissions and offering costs, consisting of $4,595,000 of underwriting commissions, $11,541,250 of deferred underwriting
commissions, and $771,938 of other offering costs related to the IPO.
There has been no material change in the planned
use of the proceeds from the Public Offering and the sale of the Private Placement Warrants as is described in the IPO Prospectus.
In connection with the consummation of the IPO,
we entered into a forward purchase agreement with Kingstown 1740 Fund, LP and Kingfishers L.P., affiliates of Kingstown Capital Partners,
LLC, collectively “Kingstown” and our Sponsor, pursuant to which Kingstown agreed that it will purchase from us up to 5,000,000
Forward Purchase Shares, for $10.00 per share, or an aggregate amount of up to $50,000,000, in a private placement that will close concurrently
with the closing of our initial Business Combination. The proceeds from the sale of these Forward Purchase Shares, together with the
amounts available to us from the Trust Account (after giving effect to any redemptions of Public Shares) and any other equity or debt
financing obtained by us in connection with the Business Combination, will be used to satisfy the cash requirements of the Business Combination,
including funding the purchase price and paying expenses and retaining specified amounts to be used by the post-Business Combination
company for working capital or other purposes. To the extent that the amounts available from the Trust Account and other financing are
sufficient for such cash requirements, Kingstown may purchase less than 5,000,000 Forward Purchase Shares. In addition, Kingstown’s
commitment under the forward purchase agreement will be subject to approval of its investment committee prior to the closing of our initial
Business Combination. Accordingly, if Kingstown’s investment committee does not give its approval, Kingstown will not be obligated
to purchase the Forward Purchase Shares. Further, we have the right, in our sole discretion, to reduce the amount of Forward Purchase
Shares that Kingstown may purchase pursuant to the forward purchase agreement. Pursuant to the terms of the forward purchase agreement,
Kingstown will have the option to assign its commitment to one of its affiliates and up to $5,000,000 to members of our management team
or board of directors. The Forward Purchase Shares will be identical to the Class A ordinary shares included in the Units sold in the
Public Offering, except that they will be subject to transfer restrictions and registration rights.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not Applicable.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.